NCT03179384View on ClinicalTrials.gov

Impact on the Intestinal Microbiota of Treatment With Ceftriaxone in Women's Acute Community Pyelonephritis

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 26, 2017

Primary Completion Date

February 5, 2019

Study Completion Date

February 5, 2019

Conditions

Pyelonephritis Acute

Interventions

DRUG

Ceftriaxone

ceftriaxone (1g intravenous or 1g/35mL intramuscular) will be given to patients during 7 days

Trial Locations (1)

06003

CHU de Nice, Nice

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT03179384 - Impact on the Intestinal Microbiota of Treatment With Ceftriaxone in Women's Acute Community Pyelonephritis | Biotech Hunter | Biotech Hunter